Injectable hydrogel loaded with lysed OK-432 and doxorubicin for residual liver cancer after incomplete radiofrequency ablation

A nanoadjuvant that dynamically coordinates innate immune stimuli activation enhances cancer immunotherapy and reduces immune cell exhaustion

(2023) Seung Mo Jin et al.   Nature Nanotechnology

Type I interferon-mediated tumor immunity and its role in immunotherapy

(2022) Renren Yu et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Blocking CD47 promotes antitumour immunity through CD103+ dendritic cell–NK cell axis in murine hepatocellular carcinoma model

(2022) Shuai Wang et al.   JOURNAL OF HEPATOLOGY

The Capsule of <b><i>Acinetobacter baumannii</i></b> Protects against the Innate Immune Response

(2022) Lavoisier Akoolo et al.   Journal of Innate Immunity

Enhanced efficacy of direct immunochemotherapy for hepatic cancer with image-guided intratumoral radiofrequency hyperthermia

(2022) Xuefeng Kan et al.   Journal for ImmunoTherapy of Cancer

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

An injectable hydrogel using an immunomodulating gelator for amplified tumor immunotherapy by blocking the arginase pathway

(2021) Xiaomeng Ren et al.   Acta Biomaterialia

Cooperative Self-Assembled Nanoparticle Induces Sequential Immunogenic Cell Death and Toll-Like Receptor Activation for Synergistic Chemo-immunotherapy

(2021) Yaoqi Wang et al.   NANO LETTERS

Advances in immunotherapy for hepatocellular carcinoma

(2021) Bruno Sangro et al.   Nature Reviews Gastroenterology & Hepatology

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

(2021) Maria Reig et al.   JOURNAL OF HEPATOLOGY

Localized cocktail chemoimmunotherapy after in situ gelation to trigger robust systemic antitumor immune responses

(2020) Yu Chao et al.   Science Advances

Recent Advances: The Imbalance of Immune Cells and Cytokines in the Pathogenesis of Hepatocellular Carcinoma

(2020) Kumar Jayant et al.   Diagnostics

Low-dose carboplatin reprograms tumor immune microenvironment through STING signaling pathway and synergizes with PD-1 inhibitors in lung cancer

(2020) Li Zhou et al.   CANCER LETTERS

Chemoembolization of liver cancer with doxorubicin-loaded CalliSpheres microspheres: plasma pharmacokinetics, intratumoral drug concentration, and tumor necrosis in a rabbit model

(2019) Bin Liang et al.   Drug Delivery and Translational Research

Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy

(2019) Liangrong Shi et al.   Nature Communications

Tumor Ablation and Therapeutic Immunity Induction by an Injectable Peptide Hydrogel

(2018) Honglin Jin et al.   ACS Nano

Topoisomerase II Inhibitors Induce DNA Damage-Dependent Interferon Responses Circumventing Ebola Virus Immune Evasion

(2017) Priya Luthra et al.   mBio

Role of intratumoral infiltrating macrophages after transarterial immunoembolization for hepatocellular carcinoma

(2016) Akira Kenjo et al.   Journal of Hepato-Biliary-Pancreatic Sciences

Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer

(2013) D. Alizadeh et al.   CANCER RESEARCH

Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer

(2013) Jun-Eul Hwang et al.   CLINICAL & EXPERIMENTAL METASTASIS

Single-step multimodal locoregional treatment for unresectable hepatocellular carcinoma: balloon-occluded percutaneous radiofrequency thermal ablation (BO-RFA) plus transcatheter arterial chemoembolization (TACE)

(2013) R. Iezzi et al.   Radiologia Medica

Prolonged recurrence-free survival following OK432-stimulated dendritic cell transfer into hepatocellular carcinoma during transarterial embolization

(2010) Y. Nakamoto et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Percutaneous Ablation of Hepatocellular Carcinoma: Current Status

(2010) Justin P. McWilliams et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Topoisomerase levels determine chemotherapy responsein vitroandin vivo

(2008) Darren J. Burgess et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA